Tue, Sep 16, 2025
[Archive]
Volume 15, Issue 4 (9-2025)
Iran J Ped Hematol Oncol 2025, 15(4): 710-715 |
Back to browse issues page
Ethics code: ABNJ
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
ASSIA H, Achouri D. Pediatric Adrenocortical Carcinoma: Diagnostic Challenges and Therapeutic Approach — A Case Report. Iran J Ped Hematol Oncol 2025; 15 (4) :710-715
URL: http://ijpho.ssu.ac.ir/article-1-843-en.html
URL: http://ijpho.ssu.ac.ir/article-1-843-en.html
Department of Pediatric Surgery, University Hospital Center of SETIF, Algeria & Department of Pediatric Surgery, University Hospital Center of SETIF, Algeria
Abstract: (21 Views)
Adrenocortical carcinoma (ACC) is a rare tumor. It constitutes 0.2% of malignant tumors in children and it is considered ten times rarer than in adults. Patients with predisposing syndromes like Li-Fraumeni or Beckwith-Wiedemann may develop these tumors.
Clinical symptoms are dominated by endocrine signs, which are present in 90% of cases. The primary cause is virtualization syndrome, which may occur alone or in conjunction with secondary symptoms caused by hypersecretion of adrenal hormones.
Imaging is indispensable in assessing the malignant nature of the adrenal tumor and its extent. Currently, surgical excision of the tumor is the cornerstone of treatment because its quality often depends on the prognosis of the disease. Adrenocortical carcinoma has a poor prognosis despite treatment, with high chances of recurrence and mortality.
Clinical symptoms are dominated by endocrine signs, which are present in 90% of cases. The primary cause is virtualization syndrome, which may occur alone or in conjunction with secondary symptoms caused by hypersecretion of adrenal hormones.
Imaging is indispensable in assessing the malignant nature of the adrenal tumor and its extent. Currently, surgical excision of the tumor is the cornerstone of treatment because its quality often depends on the prognosis of the disease. Adrenocortical carcinoma has a poor prognosis despite treatment, with high chances of recurrence and mortality.
Type of Study: case report |
Subject:
General
Received: 2024/02/29 | Accepted: 2025/08/27 | Published: 2025/09/19
Received: 2024/02/29 | Accepted: 2025/08/27 | Published: 2025/09/19
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
